In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration

摘要

The invention relates to the in vivo release of endogenous anti-microbial mediators using leukotriene B4 administration. The present invention furthermore relates to the use of leukotriene B4 for the treatment and/or prophylaxis of diseases that are positively influenced by such anti-microbial mediators.